| |
| |
|
| Insider
Information: |
Deerfield Private Design Fund Iv, L.p. |
| Relationship: |
Director, 10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
43,134,325 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$50,710,119 |
|
|
| Total
Shares |
43,134,325 |
|
|
| Total
Value |
$50,710,119 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DFB Healthcare Acquisitions Corp |
DFBHU |
* Director by Deputiza... |
2018-02-21 |
0 |
2019-11-08 |
20,000 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Possible Member of a 1... |
2018-10-01 |
0 |
2018-10-01 |
411,244 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
Possible Member of 10%... |
2021-03-30 |
0 |
2021-03-30 |
3,933,137 |
Premium* |
|
|
Singular Genomics Systems, Inc. |
OMIC |
*Possible Member of 10... |
2021-06-01 |
0 |
2021-06-01 |
1,627,148 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
* Director by Deputiza... |
2021-06-30 |
0 |
2022-09-16 |
2,777,777 |
Premium* |
|
|
Nuvalent, Inc. |
NUVL |
* Director by deputiza... |
2021-08-02 |
0 |
2022-11-03 |
19,991,024 |
Premium* |
|
|
Oncology Institute |
TOIIW |
Possible Members of 10... |
2021-11-12 |
0 |
2021-11-12 |
3,296,067 |
Premium* |
|
|
Silverback Therapeutics, Inc. |
SBTX |
Director, 10% Owner |
|
0 |
2022-11-08 |
11,077,928 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SBTX |
Silverback Therapeutics, ... |
Director |
– • • |
2022-11-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,077,928 |
|
- |
|
| NUVL |
Nuvalent, Inc. |
* Director by deputization |
– • • |
2022-11-03 |
4 |
B |
$33.50 |
$21,775,000 |
I/I |
650,000 |
650,000 |
2.25 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
* Director by Deputization |
– • • |
2022-09-16 |
4 |
B |
$3.15 |
$34,999,990 |
I/I |
11,111,108 |
2,777,777 |
2.25 |
- |
|
| TOIIW |
Oncology Institute |
Possible Members of 10% Group |
– – • |
2021-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
85,153 |
85,113 |
0 |
- |
|
| NUVL |
Nuvalent, Inc. |
Director by Deputization |
– • • |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
I/I |
18,783,622 |
9,670,511 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
* Director by Deputization |
– • • |
2021-06-30 |
4 |
B |
$8.75 |
$5,999,963 |
I/I |
685,710 |
1,943,420 |
2.25 |
- |
|
| OMIC |
Singular Genomics Systems... |
*Possible Member of 10% Group |
– – • |
2021-06-01 |
4 |
B |
$22.00 |
$33,000,000 |
I/I |
1,500,000 |
1,627,148 |
1.5 |
- |
|
| OMIC |
Singular Genomics Systems... |
*Possible Member of 10% Group |
– – • |
2021-06-01 |
4 |
A |
$0.00 |
$20,315,610 |
I/I |
7,612,019 |
577,148 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Possible Member of 10% Group |
– – • |
2021-03-30 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
3,933,137 |
1.5 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
Possible Member of 10% Group |
– – • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
3,308,137 |
3,308,137 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
* Director by Deputization |
– • • |
2019-11-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(658,340) |
20,000 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
* Director by Deputization |
– • • |
2019-11-08 |
4 |
A |
$10.00 |
$124,000,000 |
I/I |
12,400,000 |
14,900,000 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Possible Member of a 10% Group |
– – • |
2018-10-01 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
411,244 |
1.5 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
Possible Member of a 10% Group |
– – • |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
921,234 |
307,078 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
* Director by Deputization |
– • • |
2018-04-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(925,761) |
26,087 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
* Director by Deputization |
– • • |
2018-02-21 |
4 |
B |
$0.00 |
$0 |
I/I |
2,500,000 |
2,500,000 |
2.17 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
